Collaborative and Subcontracted Projects Offered by the Stem Cell Facility

• Generation of patient specific hiPSCs

• CRISPR modifications of hESCs/hiPSCs

• Expression of genes of interest in hESCs/hiPSCs

•  Drug or small molecule screening

• Targeted differentiation of patient derived hiPSCs

• Toxicology in pluripotent and differentiated cell types

• Endothelial barrier models to assess drug availability

• Generation of organoids

• Vascularization of organoids

• Advanced imaging techniques